Life Spine(R) Announces FDA Clearance Of FS3(TM) Minimally Invasive Spinal System

Life Spine announced today that the U.S. Food and Drug Administration (FDA) has given 510(k) marketing clearance to the FS3 Minimally Invasive Spinal System. Available for nationwide release this August, the FS3 MIS Spinal System offers cannulated wire guided Minimally Invasive Surgery implants and instrumentation to accommodate a range of patient pathologies through a percutaneous or open approach.

source : www.medicalnewstoday.com

Related News:

• European Medicines Agency Makes Recommendations To Minimise Risk Of…
• Breast Enhancement Surgeon on Long Island Nominated a "Best Of"
• $16 Million Grant From State Stem Cell Agency To Speed Research Of…
• Book and Media Reviews: American Psychiatric Publishing Textbook of…
• After Mastectomy: Making a Decision About Breast Reconstruction
• Robotic Surgery Expert Dr. David B. Samadi Discusses The Benefits Of…
• UM Doctor To Lead Clinical Trial For ALS
• Migraine as inspiration
• Impax Pharmaceuticals Reports Positive Results of Phase II Trial of…
• Analysis of TB treatment studies identifies gaps in guidelines

Details :
Submited at Friday, July 10th, 2009 at 8:01 am on Orthopaedic by madison
Comment RSS 2.0 - leave a comment - trackback